Skip to main content
Clinical Trials/NL-OMON53538
NL-OMON53538
Recruiting
Not Applicable

Objective Neurocognitive assessment of young children with sickle cell disease by eye-tracking - ONSET

Amsterdam UMC0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
sickle cell anemia
Sponsor
Amsterdam UMC
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • \- Diagnosis of SCD (SCD group);
  • \- Age 6 \- 24 months old;
  • \- Inhabitant of the Netherlands;
  • \- Written informed consent from parent/caretaker;

Exclusion Criteria

  • \- Refused informed consent from parents/care\-taker;
  • \- Diagnosis of visual impairment;
  • \- Diagnosis of a (co\-morbid) congenital developmental condition
  • \- Any neurological condition, unrelated to SCD, that could affect the central
  • nervous system, such as brain trauma, epilepsy and meningitis/encephalitis.

Outcomes

Primary Outcomes

Not specified

Similar Trials